New stock news | Xizi Health Hong Kong stock IPO prospectus failed
Hunan Xizi Health Group Co., Ltd. (referred to as Xizi Health) submitted its Hong Kong stock prospectus on January 8, 2026, which expired after 6 months on July 8, 2026. CITIC Securities was the exclusive sponsor when submitting the application.
Hunan Xizi Health Group Co., Ltd. (referred to as Xizi Health) submitted its Hong Kong stock prospectus on January 8, 2026, which expired after 6 months on July 8, 2026. CITIC SEC was the sole sponsor at the time of the submission.
The prospectus states that Xizi Health is a sports nutrition and functional food company dedicated to providing consumers with high-quality nutritional health products and leading a healthy lifestyle. The company's main products include protein powder, compound whey protein powder, creatine, functional gummies, coffee, etc.
Related Articles
.png)
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.
US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.
GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.
CSPC PHARMA (01093) has received a $25 million research and development milestone payment from AstraZeneca under a strategic collaboration and licensing agreement.
US Stock Market Move | Concept stocks related to optical communication generally fell, with Applied Optoelectronics (AAOI.US) dropping more than 6%.
GUMING (01364) spent HK$5.758 million to repurchase 288,000 shares on July 10th.
RECOMMEND
